[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Catenae Innovation Plc LSE:CTEA London Ordinary Share GB00BKM6CG53 ORD 0.2P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 0.825 145,843 08:00:00
Bid Price Offer Price High Price Low Price Open Price
0.80 0.85 0.825 0.825 0.825
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 0.10 -0.97 -3.00 2
Last Trade Time Trade Type Trade Size Trade Price Currency
10:53:39 O 39,961 0.8035 GBX

Catenae Innovation (CTEA) Latest News

More Catenae Innovation News
Catenae Innovation Investors    Catenae Innovation Takeover Rumours

Catenae Innovation (CTEA) Discussions and Chat

Catenae Innovation Forums and Chat

Date Time Title Posts
28/9/202111:15CTEA - blockchain...an interesting one10,569
02/8/202119:16Interesting Presentation646
02/8/202119:16Catenae (CTEA) One to Watch 100
02/8/202119:16CTEA - An opportunity or dead in the water 18
02/8/202119:14Catenae Innovation PLC193

Add a New Thread

Catenae Innovation (CTEA) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
09:53:410.8039,961321.09O
09:01:090.855,88250.00O
07:59:590.8050,000401.75O
07:28:340.8050,000401.10O
View all Catenae Innovation trades in real-time

Catenae Innovation (CTEA) Top Chat Posts

DateSubject
28/9/2021
09:20
Catenae Innovation Daily Update: Catenae Innovation Plc is listed in the Media sector of the London Stock Exchange with ticker CTEA. The last closing price for Catenae Innovation was 0.83p.
Catenae Innovation Plc has a 4 week average price of 0.83p and a 12 week average price of 0.78p.
The 1 year high share price is 4.85p while the 1 year low share price is currently 0.78p.
There are currently 281,220,744 shares in issue and the average daily traded volume is 1,639,723 shares. The market capitalisation of Catenae Innovation Plc is £2,320,071.14.
09/8/2021
07:22
sweepie2: Albeit the revenues created from the order are not significant, the Company is pleased to be working with SaxaVord on this exciting project. Until they stop adding this statement to their announcements about contracts and deals the share price will only move a a days spike fed by dreamers before falling back as reality hits home
02/8/2021
17:19
knigel: The trolls can mock while the share price rises - no skin off my nose
02/8/2021
17:15
shanew48: CTEA is a £3.8M company £1.035M in cash £18BN NHS contract slice via the ProMake led consortium. It’s all there on BidStats the UK GOV procurement website £18BN slide for ProMakd, and now for £3.8M CTEA and £32M HAYD too! hxxps://bidstats.uk/tenders/?q=ProMake The wider market doesn't seem to have digested the importance of todays update yet but they should have by the end of this week, won't be surprised to then see the share price beyond 5p then.
02/8/2021
15:05
pwhite73: KNIGEL - "(maybe because they have lost the lot already)" That's right in companies like CTEA. Oh and by the way this contract with ProMake Ltd are you aware they were only incorporated in September 2020. https://find-and-update.company-information.service.gov.uk/company/12888146 One of the directors resides in South Africa. Is there a link with AfrikID a company that CTEA part owns?
02/8/2021
12:36
demark: the share price reaction appears to suggest the market might be expecting news feed from the bods'! time will tell!! technically ctea is worth £5.34m @ 1.4p per share! issued shares 273m deferred shares 32m warrants 75m options 1.6m total 382m
02/8/2021
07:18
david gruen: 02/08/2021 7:00am RNS Non-Regulatory TIDMCTEA Catenae Innovation PLC 02 August 2021 2 August 2021 Catenae Innovation PLC ("Catenae" or the "Company") Collaboration agreement with ProMake Limited Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, announces that it has signed a collaboration agreement with ProMake Limited ("ProMake"), a global specialist in material science and medical innovations. Under the terms of the agreement, Catenae will be the exclusive provider of data management services to ProMake to fulfil its position on the Public Health England ("PHE") National Microbiology Framework. ProMake has unique intellectual property and technology that utilises graphene and other nano-materials within an injection moulded 'PreVent' tube, which a patient blows into in order to provide medical samples. The test may be used to diagnose many different diseases using a much less invasive method and at a potentially lower cost to conventional methods. Initially, the PreVent tube will be processed in a lab but ProMake's aim is to build an inexpensive 'Bio-Pod' device that will analyse the sample locally and pass data to a cloud based platform for diagnosis via an individual's mobile app. The National Microbiology Framework, announced by PHE in November 2020, supports the newly formed UK Health Security Agency (UKHSA) and the Government's effort to provide a broad range of medical testing and diagnostic services for people in the UK. More information on the Framework can be found via this link: hxxps://www.government-online.net/national-microbiology-framework-public-health-england/ Catenae forms part of a ProMake led consortium which has been awarded positions in Lot 2 (Research and Development Goods and Services) and Lot 4 (Clinical Laboratoty Diagnostic Testing Services) of the PHE Framework Agreement. Other consortium members include Haydale Graphene Industries plc (AIM:HAYD), the advanced materials group that will be the manufacturing and exclusive nano materials partner to the consortium. Haydale recently made the following announcement in relation to the ProMake led consortium, which can be found via this link: hxxps://www.haydale-ir.com/content/news/archive/2021/120721 Catenae's role within the consortium will be to securely capture and process patient and test data, control access to that data in a compliant manner and provide reporting services through dashboards, mobile apps, web and blockchain technology. ProMake's intention is to automate all aspects of the supply chain from the manufacture, distribution and use of the Pre-Vent tubes through to their ultimate disposal. Catenae will manage the data throughout that supply chain and where appropriate make the data available to individuals and organisations. Under this collaboration agreement, Catenae will also provide consulting services to support ProMake in its engagement with the organisations able to access the Framework Agreement, which includes: -- Public Health England; -- Department of Health and Social Care; -- Public Health Wales; -- Public Health Scotland; -- Department for Health for Northern Ireland; -- Health and Social Care Northern Ireland; -- NHS Authorities, NHS Trusts, NHS Foundation Trusts, Special Health Authorities, NHS Scotland Health Boards, NHS Wales Health Boards, NHS Northern Ireland Health Boards, Special NHS Boards and any other NHS entity; -- Local Authorities; -- Any other bodies governed by public law (as defined in regulation 2 of the Public Contracts Regulations 2015 (SI 2015/102) (as amended); and -- Academic or charitable institutions (including any such institutions that are not Contracting Authorities). The Catenae Board considers that it is premature to provide any guidance as to the timing or value to Catenae of this collaboration, but anticipates being able to give a more detailed update in the coming months. Guy Meyer, Chief Executive Officer of Catenae, said: "We are delighted to announce this collaboration agreement with ProMake to support its work within the Public Health England National Microbiology Framework. Our provision of data management services and support in Lots 2 and 4 of the framework demonstrates the digital transformational application of Catenae's innovative technologies, as well as the Company's continued commitment to delivering people centric technology solutions. "Our data management services can be successfully applied to a number of sectors and industries, with Covid-19 testing and related services a continued area of work for Catenae." Jason Laing, Co-Founder and CEO of ProMake, said: "On behalf of ProMake, I would like to thank Catenae for the support it has given us through this tender process. We are excited to work with Catenae and employ its data management services to fulfil our position on the National Microbiology Framework."
20/7/2021
17:29
alancapone: PWhite73 - 11 Apr 2021 - 16:59:40 - 9661 of 10201 CTEA - blockchain...an interesting one - CTEA pakenham - There is one area that would be hugely commercial for a company like CTEA if it were to land a government contract and its international travel. The government are toying with a traffic like system for certain countries and a system where overseas travellers can reduce the amount of time they stay in quarantine if they can prove they are vaccinated, have recently tested negative or prove they have antibodies. CTEA are ahead of the game in this area with Afrik-ID. The government could say look as you're already on the African continent we will issue an edict to certain countries that they must have a certificate/passport issued by yourselves before they can enter the UK. https://www.bbc.co.uk/news/uk-56686347 Tests for all travellers in 'traffic light' plan The UK government has given more detail on the resumption of international travel. A traffic light system to categorise countries based on risk will include a watch list for those countries that could move from "green" to "amber". But a requirement for travellers to pay for Covid tests when departing and returning to the UK has left the travel industry frustrated" RNS 05/11/2020 - "David Newman, Chairman and Chief Executive Officer of Afrik-ID, said: "Afrik-ID has been assessing the market for Catenae solutions into the SADC region." So who are the SADC countries? https://en.wikipedia.org/wiki/Southern_African_Development_Community "Angola, Botswana, Comoros, Democratic Republic of Congo, Eswatini, Lesotho, Madagascar, Malawi, Mauritius, Mozambique, Namibia, Seychelles, South Africa, Tanzania, Zambia and Zimbabwe."
11/5/2021
17:13
k1ngkonggb: I really don't care whether CTEA have any clue, so long as the share price hits 4p!!!
28/4/2021
15:23
davevt: Wow the mental gymnastics of the desperate on LSE.. 'To all the derampers who are using 'NHS App' to scare people to sell out, can you show me where it says CTEA have not been involved in developing the NHS App?' Well by that logic I could suggest Build A Bear Workshop could be involved as I haven't seen anywhere saying they are not.. 🤣 How about the fact it's been widely publicized which companies have been working with them and system integration, and ctea wasn't one of them. No one was keeping the companies involved 'a secret', and seeing as ctea put out an rns for when they even change a toilet roll, you soon would have known.. Ctea don't have to tell you they are 'not' doing something, because there are infinite things they are not doing. They are not currently re paving my driveway. Would you like them to tell you that? It's gonna be a bloody big list..
12/4/2021
08:33
davevt: Beeks, I'm not missing the point. When do I ever discuss the share price? Never. It's irrelevant to me. I only discuss the company. I'm the last one to talk about price, I bought loads at 0.02 and sold at 2, but that's nothing to do with what the company was doing. Prices will go up and down, and for every person who gets a bit, another loses. I wish you'd stop bleating on about an interim price as if it matters to me....guess what, all shares rise on speculation 😂 But guess what, the more this happens, the more people get locked in, and then frustrated sell to get out, saturating further rises. Hence why ramping is ultimately counterproductive. When nothing happens today with news or price, the next round of ramping, more desperate, will fall on deaf ears.
Catenae Innovation share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
CTEA
Catenae In..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210928 10:16:43